| The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner G Clarke, S Grenham, P Scully, P Fitzgerald, RD Moloney, F Shanahan, ... Molecular psychiatry 18 (6), 666-673, 2013 | 2107 | 2013 |
| Targeting the microbiota-gut-brain axis: prebiotics have anxiolytic and antidepressant-like effects and reverse the impact of chronic stress in mice A Burokas, S Arboleya, RD Moloney, VL Peterson, K Murphy, G Clarke, ... Biological psychiatry 82 (7), 472-487, 2017 | 957 | 2017 |
| Gut microbiota depletion from early adolescence in mice: Implications for brain and behaviour L Desbonnet, G Clarke, A Traplin, O O’Sullivan, F Crispie, RD Moloney, ... Brain, behavior, and immunity 48, 165-173, 2015 | 828 | 2015 |
| The microbiome: stress, health and disease RD Moloney, L Desbonnet, G Clarke, TG Dinan, JF Cryan Mammalian genome 25, 49-74, 2014 | 542 | 2014 |
| The impact of microbiota on brain and behavior: mechanisms & therapeutic potential YE Borre, RD Moloney, G Clarke, TG Dinan, JF Cryan Microbial endocrinology: The microbiota-gut-brain axis in health and disease …, 2014 | 429 | 2014 |
| Stress and the microbiota–gut–brain axis in visceral pain: relevance to irritable bowel syndrome RD Moloney, AC Johnson, SM O'mahony, TG Dinan, ... CNS neuroscience & therapeutics 22 (2), 102-117, 2016 | 405 | 2016 |
| Microbiota regulation of the mammalian gut–brain axis A Burokas, RD Moloney, TG Dinan, JF Cryan Advances in applied microbiology 91, 1-62, 2015 | 355 | 2015 |
| Prenatal stress-induced alterations in major physiological systems correlate with gut microbiota composition in adulthood AV Golubeva, S Crampton, L Desbonnet, D Edge, O O'Sullivan, ... Psychoneuroendocrinology 60, 58-74, 2015 | 308 | 2015 |
| Behavioural and neurochemical consequences of chronic gut microbiota depletion during adulthood in the rat AE Hoban, RD Moloney, AV Golubeva, KAMV Neufeld, O O’Sullivan, ... Neuroscience 339, 463-477, 2016 | 288 | 2016 |
| Stress-induced visceral pain: toward animal models of irritable-bowel syndrome and associated comorbidities RD Moloney, SM O’Mahony, TG Dinan, JF Cryan Frontiers in psychiatry 6, 15, 2015 | 192 | 2015 |
| Microbial regulation of microRNA expression in the amygdala and prefrontal cortex AE Hoban, RM Stilling, G M Moloney, RD Moloney, F Shanahan, ... Microbiome 5, 1-11, 2017 | 170 | 2017 |
| Microbial endocrinology: the microbiota-gut-brain axis in health and disease YE Borre, RD Moloney, G Clarke, T Dinan, J Cryan Adv Exp Med Biol [Internet] 17 (4), 2014 | 163 | 2014 |
| Early‐life stress‐induced visceral hypersensitivity and anxiety behavior is reversed by histone deacetylase inhibition RD Moloney, RM Stilling, TG Dinan, JF Cryan Neurogastroenterology & Motility 27 (12), 1831-1836, 2015 | 104 | 2015 |
| “Braking” the prefrontal cortex: the role of glucocorticoids and interneurons in stress adaptation and pathology JM McKlveen, RD Moloney, JR Scheimann, B Myers, JP Herman Biological Psychiatry 86 (9), 669-681, 2019 | 98 | 2019 |
| Toll-like receptor 4 regulates chronic stress-induced visceral pain in mice M Tramullas, BC Finger, RD Moloney, AV Golubeva, G Moloney, ... Biological psychiatry 76 (4), 340-348, 2014 | 96 | 2014 |
| Early-life stress induces visceral hypersensitivity in mice RD Moloney, OF O’Leary, D Felice, B Bettler, TG Dinan, JF Cryan Neuroscience letters 512 (2), 99-102, 2012 | 93 | 2012 |
| Enduring behavioral effects induced by birth by caesarean section in the mouse LH Morais, AV Golubeva, GM Moloney, A Moya-Pérez, AP Ventura-Silva, ... Current Biology 30 (19), 3761-3774. e6, 2020 | 92 | 2020 |
| Targeting epigenetic mechanisms for chronic pain: a valid approach for the development of novel therapeutics CO Ligon, RD Moloney, B Greenwood-Van Meerveld Journal of Pharmacology and Experimental Therapeutics 357 (1), 84-93, 2016 | 54 | 2016 |
| Mechanisms of stress‐induced visceral pain: implications in irritable Bowel syndrome B Greenwood‐Van Meerveld, RD Moloney, AC Johnson, M Vicario Journal of neuroendocrinology 28 (8), 2016 | 44 | 2016 |
| Metabotropic glutamate receptors in central nervous system diseases A V Golubeva, R D Moloney, R M O'Connor, T G Dinan, J F Cryan Current drug targets 17 (5), 538-616, 2016 | 44 | 2016 |
